A4XKR2 AF NFT

Isoleucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeig6aow6cgvdneg2vnokk7xdu3kkq4c57c6deze4sapzh5kf7oenqe/metadata.json
IPFS of structure file: 
bafybeigu57ql2t3nd6hfv226vtfmna2xynpekplghtlbwttczddzxa5tcq/AF-A4XKR2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5BeA89782341f98147F2D811B063F91F0aE7D7bF
First NFT owner address (bech32): 
genesis1t04gj7prg8ucz3ljmqgmqcleru9w04al6k7v50
Current NFT ID #448811 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
448811
Accession (UniProt):
A4XKR2
Name::
Isoleucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Caldicellulosiruptor saccharolyticus (strain ATCC 43494 / DSM 8903 / Tp8T 6331)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A4XKR2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A4XKR2|SYI_CALS8 Isoleucine--tRNA ligase OS=Caldicellulosiruptor saccharolyticus (strain ATCC 43494 / DSM 8903 / Tp8T 6331) OX=351627 GN=ileS PE=3 SV=1 MDWSQTLNLPKTDFPMRANLAQREPQFLRFWEENDIFKKMLKKNRNNKKFILHDGPPYANGDIHLGHALNKVLKDIVNKYKSLQGYYTPYIPGWDTHGLPIEQQVIKKLGVNRHEVDPVEFRKKCKEFALSYIDIQRQQFKRLGVFGEWEDPYMTLDPKFEARQIRVFGEMAKKGYIYKGLKPVYWCPSCETALAEAEIEYQEDKTYSIYVKFEVIDDKGLFANLNLSGKKVYIVIWTTTTWTLPGNLAIALNTDFDYSLVDVGNEILIVASELVERVMKTNKIDQYHEIARFKGKDLEYVKCKHPFLDRTSLVILGEHVTLEAGTGCVHTAPGHGEEDFEVCERYNIPVIVPVDNKGYLTQEAGKFAGLFYEDSNKEIAKELEASDHLLGVEKITHQYPHCWRCKNPVIFRATEQWFASVKGFREEALKAVDDVKWVPEWGRDRIYNMIADRQDWCISRQRIWGVPIPIFYCKNCRKELITDETIDHIAKIFEKEGSDAWFSKDVKELLPEGTKCPVCGCMEFEKETDIMDVWFDSGSSHAYVLESREDLEWPCDMYLEGNDQYRGWFQSSLLTAVATKGRAPYRIVLTHGFVVDGEGKKMSKSEGNVISPFDIINEFGADILRLWCVSADYTTDMRISKDIIKQLTEIYRKIRNTARFLLGNLYDFNPKTDKVGCENLKEIDKWALQRLYKLIEKVTKAYEEYDYNQVYHLVHNFCVIDMSNLYLDINKDRLYASKSESLDRRSAQTVMYEILVALTKLIAPILSFTAEEIWQNIIFKEEDAESVFLTSWPKVNENILKDETLEEKWNKIIEIKDIVAKQLEIARNEKLIGSSLDSKVKIFAKGNIKRFIEENKDIIQEVLIVSQLEVEEGDSDQIKVEVYKADGLKCERCWKFDTMVGKNEENLNVCPRCYEVVKVK